about
Human UDP-α-D-xylose synthase and Escherichia coli ArnA conserve a conformational shunt that controls whether xylose or 4-keto-xylose is producedHeparin: Past, Present, and FutureSurface Proteoglycans as Mediators in Bacterial Pathogens InfectionsBiological findings from the recent NMR-based studies of glycosaminoglycan-protein interactionsHuman genetic disorders and knockout mice deficient in glycosaminoglycanNewborn screening and diagnosis of mucopolysaccharidosesDimerization effect of sucrose octasulfate on rat FGF1Catalytic Mechanism of Heparinase II Investigated by Site-directed Mutagenesis and the Crystal Structure with Its SubstrateStructural basis of heparan sulfate-specific degradation by heparinase IIIHeparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfationSulfatase 1 is an inhibitor of ductal morphogenesis with sexually dimorphic expression in the urogenital sinusMice deficient in heparan sulfate 6-O-sulfotransferase-1 exhibit defective heparan sulfate biosynthesis, abnormal placentation, and late embryonic lethalityEnzymatic synthesis of heparin related polysaccharides on sensor chips: rapid screening of heparin-protein interactions.The effect of proteoglycans inhibited by RNA interference on metastatic characters of human salivary adenoid cystic carcinoma.Ovarian cancer cell heparan sulfate 6-O-sulfotransferases regulate an angiogenic program induced by heparin-binding epidermal growth factor (EGF)-like growth factor/EGF receptor signalingA mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes.Glycomics analysis of mammalian heparan sulfates modified by the human extracellular sulfatase HSulf2.Chemical Tumor Biology of Heparan Sulfate Proteoglycans.CS lyases: structure, activity, and applications in analysis and the treatment of diseasesAcceptor specificity of the Pasteurella hyaluronan and chondroitin synthases and production of chimeric glycosaminoglycans.Oligosaccharide substrate preferences of human extracellular sulfatase Sulf2 using liquid chromatography-mass spectrometry based glycomics approaches.Gene silencing of EXTL2 and EXTL3 as a substrate deprivation therapy for heparan sulphate storing mucopolysaccharidoses.Phosphorylation and sulfation of oligosaccharide substrates critically influence the activity of human beta1,4-galactosyltransferase 7 (GalT-I) and beta1,3-glucuronosyltransferase I (GlcAT-I) involved in the biosynthesis of the glycosaminoglycan-proCrystal structure of heparinase II from Pedobacter heparinus and its complex with a disaccharide product.Heparan sulfate proteoglycans.Applications of isotopes in advancing structural and functional heparanomics.Environmental and gut bacteroidetes: the food connection.Metabolic engineering of Chinese hamster ovary cells: towards a bioengineered heparinHuman metapneumovirus (HMPV) binding and infection are mediated by interactions between the HMPV fusion protein and heparan sulfate.Reduced Expression of EXTL2, a Member of the Exostosin (EXT) Family of Glycosyltransferases, in Human Embryonic Kidney 293 Cells Results in Longer Heparan Sulfate Chains.Mutated Leguminous Lectin Containing a Heparin-Binding like Motif in a Carbohydrate-Binding Loop Specifically Binds to Heparin.A processive carbohydrate polymerase that mediates bifunctional catalysis using a single active site.Expanding the role of 3-O sulfated heparan sulfate in herpes simplex virus type-1 entryDrosophila heparan sulfate, a novel design.Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor.Toward a bioengineered heparin: challenges and strategies for metabolic engineering of mammalian cellsLinear polyalkylamines as fingerprinting agents in capillary electrophoresis of low-molecular-weight heparins and glycosaminoglycans.Structural remodeling of proteoglycans upon retinoic acid-induced differentiation of NCCIT cells.Extracellular matrix in the trabecular meshwork.Xyloside-primed Chondroitin Sulfate/Dermatan Sulfate from Breast Carcinoma Cells with a Defined Disaccharide Composition Has Cytotoxic Effects in Vitro.
P2860
Q24301032-9715F348-19A7-4E9C-8F17-74CF201DC1E7Q26744227-3D815493-3ED1-416D-BBDF-858EBB1C5B4AQ26768544-8AD2E851-4178-4F7B-9E57-F3B45548ED8FQ26863773-2DFF0AEE-9624-4895-975E-CBDE2BF50594Q26995332-35D74487-B3C0-4F32-A424-96269CDB601CQ27025080-D3DA426E-E079-4768-AA12-19C19A0F7F28Q27650780-0FE8224B-DBED-4D45-B87A-E629AC69C0D9Q27660652-47923755-64DE-4AD5-93E7-10E0E4A56B37Q27673616-03BD4E4C-9B08-4223-AD0A-0A9913CCC04DQ28115828-45022F97-7243-4065-A035-B01583FC0671Q28592245-2EC81C5F-30FC-4538-B692-DA0562C58970Q28592475-AB0FF5C8-F36A-40AD-A3E0-068B75CEC62FQ33227881-FE9A90A4-1F99-4F4A-A2B4-E428A06DDC4CQ33520086-1FA12E47-3359-4F61-9F25-6E769A28BC15Q33675726-273F7E25-61A2-45EB-AC49-8FEE11808F22Q33719846-763501C9-E682-485C-AC56-01CB3D736BDEQ33828849-0282F9B8-D50F-4F05-B8EF-E81F645C156AQ33944132-6CDFF305-B172-4FD2-8F7D-B2B706553100Q33965779-135E5A99-0FBC-4DEB-9879-3BA581C2E08FQ33981318-B2A4CE44-7B8C-406D-B8CA-6C6C3EE0996CQ34050837-C1432FA0-763B-4720-BF33-DC35B6965FF1Q34328525-9D2BE2FF-8E3A-48D0-B397-35643A703270Q34364558-783FB4F5-3EA8-45C3-A712-F04A57CA3FEDQ34505592-53E073D3-19BA-4736-BAF2-6D6315F1CA80Q35059448-A108AE4B-CFE6-4B85-AB94-CF5EDD075E3DQ35083201-C22175E1-99E4-49D2-98DD-7F84A2542A21Q35084646-6AE320A2-B269-4317-8BBF-09BEEF6A5128Q35821387-6CC6A138-5D35-44E2-AFA9-0A7FFAD03E78Q35826221-AAB3CFEE-E321-4F19-A785-3ACE34BC3FF8Q35860945-E0ADDA2E-2250-4386-A673-C954583FD709Q35880727-4872FC98-E1DB-46FA-B95C-B655937D2A17Q35888888-FD5B2900-EB17-4341-B500-4B667747BB7EQ35955720-6B6E9D85-3F07-4681-AFB9-5985F02C2BD8Q36052448-93D125DC-502B-4FCC-95C0-6D37F703A031Q36332838-471E0024-DFCC-472A-B5A3-A2DD82236FE6Q36334479-9B440D38-0F9A-49D4-8F6E-3FBC3E09455AQ36452315-ED0D5434-8650-44FD-B4F4-B07A0F250921Q36565975-0C5ED2E0-7C02-45DA-B319-7A60FD3631F2Q36646381-F11F8AAA-409C-4F49-A207-338C61DE4F92Q37078727-808F9480-0B5A-475D-A0AA-C4E6E1F1F6A3
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Heparin and heparan sulfate biosynthesis.
@ast
Heparin and heparan sulfate biosynthesis.
@en
type
label
Heparin and heparan sulfate biosynthesis.
@ast
Heparin and heparan sulfate biosynthesis.
@en
prefLabel
Heparin and heparan sulfate biosynthesis.
@ast
Heparin and heparan sulfate biosynthesis.
@en
P356
P1433
P1476
Heparin and heparan sulfate biosynthesis.
@en
P2093
Hiroshi Kitagawa
Kazuyuki Sugahara
P304
P356
10.1080/15216540214928
P577
2002-10-01T00:00:00Z